Shares of U.S. health insurers climbed as analysts said Pres. Barack Obama's highly anticipated speech urging Congress to act on health reform revealed no "game changers." Thomas Carroll, analyst at Stifel Nicolaus, and David Joy, chief market strategist at RiverSource Investments, shared their insights on the industry.
Stocks fell to the lows of the day this afternoon as a couple of issues weighed on the markets.
Health services firm Health Net has been rising for the last month and is up another 6 percent Wednesday amid heavy options volume. In the first 90 minutes of the session alone, HNT contracts had already traded more than seven times the 20-day average. Find out what it means.
The markets got off to a rough start on Inauguration Day, but Brent Wilsey predicts a honeymoon on Wall Street as Barack Obama moves into the White House. "When I feel the optimism today, how excited everybody is, I think he will have some honeymoon here," the president of Wilsey Asset Management told CNBC.
Cramer last week offered up his prediction of potential winners from the new Medicare bill -- the one that passed in the Senate yesterday. (President Bush has said he'll veto -- but it already passed by a veto-proof margin.) The good news is that Fresenius Med (FMS), Cramer's fave of the bill, got bumped to a 52-week high today with three points. But what about the losers of the Medicare bill -- the new offenders headed for the Sell Block?
Aetna shares dropped 5 percent and Health Net tumbled 10 percent after a Goldman Sachs analyst slapped "sell" ratings on the two health insurers' stocks Thursday.
As crude oil went higher stocks went lower Tuesday. What's the "Word on the Street?"
With stocks sharply lower today, shareholders need to protect their portfolios. So what are some of the best defensive stock picks? CNBC asked the experts.
Health insurer Humana slashed its first-quarter earnings forecast by nearly half Wednesday based on new projections for its Medicare plans for the elderly that provide prescription drug coverage.
The 110th session of the U.S. Congress opens in less that one week--and the Democrats are back in power in both the house and senate. One of their stated goals is making health care more affordable for Americans. But is that good news or bad news for HMOs? And either way--which healthcare stocks should investors look at?